A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text

Medicine, Oncology, Radiation Oncology +12

A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

Manfred Westphal, Dana Hilt, Enoch Bortey et al. · Neuro-Oncology · 2003 · 1.3K citations · Full text

Medicine, Oncology, Surgery +17

Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials

W.J. Curran, Charles Scott, John Horton et al. · JNCI Journal of the National Cancer Institute · 1993 · 1.3K citations

Medicine, Oncology, Radiation Oncology +10

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

Edward R. Laws, Ian F. Parney, Wei Huang et al. · Journal of neurosurgery · 2003 · 667 citations

Medicine, Oncology, Surgery +17

Descriptive epidemiology of primary brain and CNS tumors: Results fromthe Central Brain Tumor Registry of the United States, 1990-1994

Tanya Surawicz, Bridget J. McCarthy, Varant Kupelian et al. · Neuro-Oncology · 1999 · 445 citations

Medicine, Oncology, Cancer Epidemiology +13